Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff

Feature | AHA

ISCHEMIA Trial Results Find Interventions for Stable Heart Disease No better Than Drug Therapy

November 19, 2019 — After 12 years of collecting data, the results of the landmark ISCHEMIA (International Study of ...

November 19, 2019

Feature | AHA | Dave Fornell, Editor

American Heart Association 2019 Late-breaking Trials

November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at the ...

November 19, 2019

Results from the MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer) study shows that an investigational set of algorithms in the Medtronic Micra Transcatheter Pacing System (TPS) significantly improves synchrony and cardiac function in patients with atrioventricular (AV) block. This is an impaired electrical conduction between the chambers of the heart.

News | Pacemakers

New Algorithms in Medtronic Micra Pacemaker May Improve Synchrony and Cardiac Function in AV Block

(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020 - FDA ...

November 15, 2019

The ClotTriever system (Inari Medical), a mechanical thrombectomy system FDA 510(k) cleared for the nonsurgical removal of soft thrombi and emboli from peripheral blood vessels. #VIVA19 #VIVA2019

News | Deep Vein Thrombosis (DVT)

DVT ClotTriever (CLOUT) Registry Shows Significant Improvement

November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...

November 14, 2019

News | Peripheral Artery Disease (PAD)

The ULYSSE Registry Shows Benefit of Ultrasoundplasty Before Below-the-knee Interventions

November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

November 14, 2019

doctor heart failure patient from CorAssist

News | AHA

Many Adults with Heart Failure at Higher Risk of Death after Surgery

November 14, 2019 — More than a million Americans face a doubling in their risk of death during or while recovering from ...

November 14, 2019

News | Peripheral Artery Disease (PAD)

Adventitial Temsirolimus Injections in BTK Lesions Improved Outcomes in TANGO Trial

November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...

November 14, 2019

The LimFlow procedure permanently bypasses unreconstructable arteries and leverages healthier veins as a conduit to create new routes to perfuse tissue in the foot. #VIVA #VIVA19 #VIVA2019

News | Peripheral Artery Disease (PAD)

LimFlow Procedure Successful in Bypassing Unreconstructable Arteries in Limb-threatening Ischemia

November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...

November 14, 2019

Cholesterol test prep blood draw needle stick from American Heart Association

News | AHA

ASCVD Patients Face Barriers Reaching Guideline-Recommended Cholesterol Goals

November 14, 2019 — A large majority of patients with atherosclerotic cardiovascular disease (ASCVD) in the NCDR ...

November 14, 2019

The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for endovascular treatment of pathologies extending or involving the aortic arch. #VIVA19 #VIVA2019

News | Endovascular Aortic Repair

Nexus Arch Branch Stent Graft System Shows Positive Mid-term Results

November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...

November 11, 2019

The repuncturable Supera vascular mimetic peripheral stent system from Abbott Vascular was shown to manage bulky, heavily calcified CFA disease due to its extreme crush resistance in the VMI-CFA study. #VIVA #VIVA19 #VIVA2019

News | Stents Carotid

Supera Safe to use for Femoral Stenting Versus Surgery in VMI-CFA Trial

November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...

November 11, 2019

Indigo System CAT RX Aspiration Catheter and Penumbra Engine

News

Indigo Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy

November 8, 2019 — Penumbra Inc. announced that the EXTRACT-PE trial successfully met the primary endpoints ...

November 08, 2019

News

One-Year Results of the DISAPEAR Registry Positive for Absorb Stent

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

November 08, 2019

News | Stents Bioresorbable

Bioresorbable Stent Shows Good 5-Year Outcomes in ABSORB BTK Trial

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

November 07, 2019

The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) were evaluated to determine if there is an increased mortality risk due to paclitaxel, but was no difference was seen in the five-year mortality rates compared to control patients. #VIVA19 #VIVA #VIVA2019

Feature | Stents Peripheral | Dave Fornell, Editor

No Increased Long-Term Mortality for the Paclitaxel-Coated Zilver PTX Stent

November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...

November 06, 2019